News
Voices of Hodgkin’s Blog
Voices of Hodgkin’s Blog

What Does it Take to Harmonize the World’s Hodgkin Lymphoma Data?

In the first episode of The HemOnc Pulse in 2024, the lead researchers of the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) consortium discuss the immense labor and fortitude it took to successfully launch the consortium, which includes a global team of diverse experts focused on the prognosis, epidemiology, treatment, survivorship, and health outcomes in patients with Hodgkin lymphoma.

A Man With Breast Cancer After Mantle Radiation

Men with breast cancer tend to have a worse prognosis than women, as they commonly have more advanced disease at diagnosis. While many practitioners utilize mammography screening for women, there is less awareness of recommendations regarding screening for men.

Significant Progression-Free Survival in Stage III/IV Classic Hodgkin Lymphoma

A Phase III trial has demonstrated that patients with advanced Stage III/IV classic Hodgkin lymphoma who underwent initial treatment with nivolumab, a PD-1 checkpoint inhibitor, and AVD chemotherapy (N-AVD) had a significantly lower risk of their cancer getting worse than patients treated with brentuximab vedotin, a monoclonal antibody, and AVD (BV-AVD) a year after starting treatment.

I’m a ‘Syringe Half-Full’ Kinda Girl

Meet Sheilagh Foley, a Hodgkin’s survivor with a familiar tale to tell, and she does it so beautifully. Hodgkin’s International was mentioned as a resource, and we are thrilled to have the “shout out!”